Try our Advanced Search for more refined results
Searching dockets in Harmony Biosciences Holdings Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Letter
Letter to The Honorable Jennifer L. Hall from Counter-Plaintiffs AET Pharma US, Inc., Sandoz AG and Sandoz Inc., and for Defendants AET Pharma US, Inc., AET Laboratories Private Limited, Alfred E. Tiefenbacher, Sandoz Inc. and Sandoz AG regarding Defendants' Letter Brief in Opposition to Plaintiffs' Motion to Strike Defendants' Fourth Affirmative Defense of Unclean Hands and Fifth Affirmative Defense of Patent Misuse - re 53 Order Setting Teleconference,,,, 61 Letter. (Gattuso, Dominick)
SO ORDERED ~Util - Set Briefing Schedule - open,ans,reply,surreply
SO ORDERED, re 63 Stipulation and Order to Extend Briefing Deadlines and Page Limits. (*Reset Briefing Schedule re 56 MOTION to Dismiss Counterclaims & 58 MOTION to Bifurcate and MOTION to Stay: Answering Brief and separate Motion to Bifurcate and Stay due 9/11/2026, 30 pages; Plaintiffs' Reply Brief and Opposition due 10/2/2026, 30 pages; Defendants' Reply Brief due 10/9/2026, 10 pages). Signed by Judge Jennifer L. Hall on 8/25/2026. (ceg)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.